MENU
FENC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fennec Pharmaceuticals (FENC) Ownership - Who owns Fennec Pharmaceuticals?
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
68 TW Alexander Drive
Phone
+1 919 636-4530
Employees
29
Web
https://www.fennecpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
227.38M
P/E Ratio
60.43
Total Cash
22.68M
Projected Growth
N/A
Total Debt
19.35M
Revenue
30.91M
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash/Share
0.82
Total Debt/Equity
N/A
Revenue/Share
1.13 USD as % of share price
Fundamentals
FENC
Capitalization
227M
P/E Ratio
60.43
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash
22.7M
Total Cash/Share
0.82
Total Debt
19.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.13%
Revenue
30.9M
ROE
N/A
Book Value
-5.88M
P/B Ratio
52.91
Cash Flow
N/A
Earnings
-0.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
146M
Current Ratio
5.13
Current Revenue Per Employee
273468.75
Dividends Per Share - Security
N/A
EBITDA
-10.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.74
Revenue To Assets
-24.98
Shares Held By Institutions
116M
Shares Outstanding - Current
27.6M
Total Liabilities
52.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
30.538
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic products based on cell adhesion
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
68 TW Alexander Drive
Phone
+1 919 636-4530
Employees
29
Web
https://www.fennecpharma.com